JAN $JAN Shares Bought by Asset Management One Co. Ltd.

Key Points

• Asset Management One increased its JAN stake by 1,764.5% in the third quarter, owning 130,326 shares valued at approximately $3.86 million. Institutional investors and hedge funds collectively own 6.27% of JAN.
• JAN’s quarterly revenue rose 45.4% year over year to $216.5 million, exceeding estimates, but EPS of $0.05 missed consensus by $0.18. Fiscal 2026 EPS guidance remains $0.95–$0.98.
• Analysts maintain a generally positive view, with a consensus “Moderate Buy” rating and an average price target of $32.31 versus the stock’s recent $28.54 price. JAN also announced a monthly dividend of $0.0475, equivalent to a 2.0% annualized yield.

Asset Management One Co. Ltd. increased its holdings in shares of JAN (NYSE:JAN - Free Report) by 1,764.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 130,326 shares of the company's stock after buying an additional 123,336 shares during the period. Asset Management One Co. Ltd.'s holdings in JAN were worth $3,862,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC bought a new stake in JAN in the 3rd quarter valued at about $27,000. Inspire Investing LLC bought a new stake in JAN during the 3rd quarter valued at $484,000. Greenland Capital Management LP bought a new stake in shares of JAN in the 2nd quarter valued at about $575,000. Sumitomo Mitsui DS Asset Management Company Ltd purchased a new position in shares of JAN in the third quarter worth $627,000. Finally, State of Alaska Department of Revenue boosted its stake in shares of JAN by 57.6% in the third quarter. State of Alaska Department of Revenue now owns 36,557 shares of the company's stock worth $1,082,000 after buying an additional 13,367 shares during the last quarter. 6.27% of the stock is owned by institutional investors and hedge funds.

More JAN News

Here are the key news stories impacting JAN this week:

• Neutral Sentiment: The most recent quarterly update remains the primary fundamental reference: JAN reported revenue of $216.5 million, up 45.4% year over year and above analyst expectations, but earnings per share of $0.05 missed consensus by $0.18.
• Neutral Sentiment: Management’s fiscal 2026 EPS guidance remains $0.95–$0.98, broadly in line with the sell-side estimate of $0.97. Investors may continue looking for evidence that earnings can improve after the latest quarterly miss.
• Neutral Sentiment: Trading volume was approximately 2.9 million shares, nearly twice the average, suggesting elevated activity despite the lack of a clearly identified JAN-specific catalyst.

Analysts Set New Price Targets

JAN has been the topic of a number of analyst reports. Wells Fargo & Company reduced their target price on shares of JAN from $35.00 to $34.00 and set an "overweight" rating on the stock in a research note on Monday, October 19th. Scotiabank raised their target price on JAN from $31.00 to $33.00 and gave the company a "sector outperform" rating in a research note on Thursday, September 17th. Compass Point started coverage on shares of JAN in a report on Wednesday, September 16th. They issued a "neutral" rating and a $37.00 price target for the company. Huntington started coverage on shares of JAN in a research note on Thursday, September 10th. They set an "outperform" rating and a $36.00 price target on the stock. Finally, Morgan Stanley boosted their price objective on shares of JAN from $28.00 to $31.00 and gave the company an "overweight" rating in a research report on Tuesday, August 18th. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, JAN presently has a consensus rating of "Moderate Buy" and an average target price of $32.31.

JAN Trading Up 0.1%

JAN stock opened at $28.54 on Monday. The business has a 50-day simple moving average of $29.68 and a two-hundred day simple moving average of $28.02. JAN has a 52-week low of $22.76 and a 52-week high of $32.83.

JAN (NYSE:JAN - Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.23 by ($0.18). The company had revenue of $216.46 million for the quarter, compared to the consensus estimate of $203.32 million. The company's revenue was up 45.4% on a year-over-year basis. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. On average, equities research analysts anticipate that JAN will post 0.97 earnings per share for the current fiscal year.

JAN Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Tuesday, December 29th. Investors of record on Friday, December 18th will be issued a $0.0475 dividend. The ex-dividend date of this dividend is Friday, December 18th. This represents a $0.57 annualized dividend and a yield of 2.0%.

JAN Profile

JanOne Inc NYSE: JAN is a social-impact and technology company focused on addressing the opioid crisis. Its activities have included the development and commercialization of solutions intended to support opioid-related treatment and prevention, with an emphasis on using business and technology to promote measurable social benefits.

Through its subsidiaries and related operations, JanOne has also pursued financial technology initiatives, including blockchain-based payment and transaction solutions.

Want to see what other hedge funds are holding JAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JAN (NYSE:JAN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.